147852-26-4 (瑞格列奈杂质E,(R)-(-)-Repaglinide (Repaglinide Impurity))

2-乙氧基-4-[2-({3-甲基-1-[2-(1-哌啶基)苯基]丁基}氨基)-2-氧代乙基]苯甲酸;瑞格列奈相关化合物E USP标准品;瑞格列奈杂质E;R-瑞格列奈;瑞格列奈EP杂质E;瑞格列奈杂质(7个);(R)-(-)-瑞格列奈(瑞格列奈杂质);

Benzoic acid,2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-;(R)-(-)-Repaglinide (Repaglinide Impurity);(R)-(-)-Repaglinide;2-ethoxy-4-[2-[[(1R)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid;AG-EE 624ZW;Repaglinide impurity E;UNII-85M30X62FM;2-Ethoxy-4-{2-{{(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino}-2-oxoethyl}benzoic acid;R-Repaglinide;Repaglinide Impurity;R-Repaglinide (Repaglinide IMpurity E);2-ethoxy-4-[2-[[(1R)-3-Methyl-1-[2-(piperidin-1- yl)phenyl]butyl]aMino]-2-oxoethyl]benzoic acid;Imp. E:2-ethoxy-4-[2-[[(1R)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid;Repaglinide specified impurity E [EP];(-)-Repaglinide;Q27269656;J-008417;SCHEMBL8141950;147852-26-4;REPAGLINIDE IMPURITY E [EP IMPURITY];AG-EE-624ZW;85M30X62FM;Benzoic acid, 2-ethoxy-4-(2-(((1R)-3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-;2-Ethoxy-4-(2-(((1R)-3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid;DTXSID70163818;2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid;Repaglinide, (-)-;CHEMBL151767;Repaglinide specified impurity E;DTXCID4086309;Repaglinide EP Impurity E;2-Ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]-benzoic Acid; (R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;REPAGLINIDE IMPURITY E (EP IMPURITY);

FAEKWTJYAYMJKF-HSZRJFAPSA-N

1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m1/s1

O=C(CC1C=CC(C(=O)O)=C(C=1)OCC)N[C@H](CC(C)C)C1=CC=CC=C1N1CCCCC1